Lilly teams up with J&J’s Synthes to find new bone healing solutions
This article was originally published in Scrip
Eli Lilly and orthopaedic trauma specialist Synthes have agreed to develop bone healing products that combine Synthes's biomaterials with Lilly's drugs. The firms hope the collaboration will uncover new ways of treating fractures and osteoporosis. Financial terms of the deal were not disclosed.
You may also be interested in...
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.